Temozolomide combined with radiation as first-line treatment in primary glioblastoma multiforme: Phase I/II-study No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results